– Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) –– One of the largest randomized…
Clinical trial advances to anticipated final cohort for INSTASYL siRNA lead product candidate PH-7625th cohort patients now being treated in…
All financial results are reported in Canadian dollars unless otherwise stated.Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus…
Los Angeles, California--(Newsfile Corp. - September 2, 2025) - Each year, more than 15,000 families in the U.S. hear the…
NOTTINGHAM, England, Sept. 2, 2025 /PRNewswire/ -- Quotient Sciences, a leading global drug development and manufacturing accelerator, and UK technology innovation…
FLORENCE, Italy, Sept. 2, 2025 /PRNewswire/ -- Medical Horizons S.r.l., (medicalhorizons.it) a leading distributor of Artificial Intelligence (AI) solutions for…
Latest additions address chronic pain, geriatrics, rheumatology, and neuromodulation, supporting more personalized and proactive outpatient care WASHINGTON, Sept. 2, 2025…
Precision, Speed, and Insight—Redefined by BioStat.AI PRINCETON, N.J., Sept. 2, 2025 /PRNewswire/ -- EDETEK Inc., a global leader in digital…
LA JOLLA, Calif., Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company…
ATLANTA, GA / ACCESS Newswire / September 2, 2025 / Ahead of its premier life science event advancing Clinical Trial…